Skip to main content
Fig. 1 | Lipids in Health and Disease

Fig. 1

From: Apolipoprotein-A is a potential prognostic biomarker for severe aplastic anemia patients treated with ATG-based immunosuppressive therapy: a single-center retrospective study

Fig. 1

Differences in blood lipids level among groups after ATG-based IST. The changes of peripheral blood lipids, including Triglycerides (TGs, A), total cholesterol (TC, B), low-density lipoprotein-cholesterol (LDL-C, C), high-density lipoprotein-cholesterol (HDL-C, D), apolipoprotein A (Apo-A, E), and apolipoprotein B (Apo-B, F were compared before and 3, 6, and 9 months after ATG-based IST among groups. Samples from healthy donor were tested as normal control group. Compared to before IST, * < 0.05, ** < 0.01; Compared to 3 M after IST, +  < 0.05, +  +  < 0.01; Compared to IST-R, ※ < 0.05; and compared to NC, ◎◎ < 0.01, ◎ < 0.05

Back to article page